Germany
· Delayed Price · Currency is EUR Shin Nippon Biomedical Laboratories Company Description
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.
It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies.
The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels.
In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants.
Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.
| Country | Japan |
| Founded | 1957 |
| Industry | Commercial Physical and Biological Research |
| Employees | 1,436 |
| CEO | Ryoichi Nagata |
Contact Details
Address: 2438 Miyanoura-cho Kagoshima, 891-1394 Japan | |
| Phone | 81 9 9294 2600 |
| Website | snbl.co.jp |
Stock Details
| Ticker Symbol | YB3 |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Ryoichi Nagata | Chief Executive Officer |
| Ryoichi Nagata | Chief Financial Officer |
| Toshiyuki Iwata | Head of Investor Relations |